Alps Advisors Inc Magenta Therapeutics, Inc. Transaction History

Alps Advisors Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.97 - $3.08 $58,620 - $186,136	-60,434 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.55 - $5.23 $19,351 - $39,690	-7,589 Reduced 11.16%	60,434 $175,000
Q4 2021 Feb 09, 2022	SELL	$4.43 - $8.33 $16,639 - $31,287	-3,756 Reduced 5.23%	68,023 $301,000
Q3 2021 Nov 15, 2021	BUY	$6.07 - $9.89 $47,054 - $76,667	7,752 Added 12.11%	71,779 $523,000
Q2 2021 Aug 11, 2021	SELL	$9.76 - $14.15 $232,473 - $337,038	-23,819 Reduced 27.11%	64,027 $626,000
Q1 2021 May 07, 2021	BUY	$7.66 - $13.38 $4,810 - $8,402	628 Added 0.72%	87,846 $1.04 Million
Q4 2020 Feb 03, 2021	BUY	$6.1 - $7.94 $156,690 - $203,954	25,687 Added 41.75%	87,218 $684,000
Q3 2020 Nov 04, 2020	BUY	$6.52 - $8.94 $49,995 - $68,551	7,668 Added 14.24%	61,531 $418,000
Q2 2020 Aug 05, 2020	BUY	$6.18 - $10.76 $332,873 - $579,565	53,863 New	53,863 $405,000
Q4 2019 Feb 07, 2020	SELL	$9.07 - $15.84 $701,392 - $1.22 Million	-77,331 Closed	0 $0
Q3 2019 Nov 04, 2019	SELL	$9.63 - $14.0 $32,202 - $46,816	-3,344 Reduced 4.15%	77,331 $793,000
Q2 2019 Aug 07, 2019	BUY	$13.4 - $17.67 $1.08 Million - $1.43 Million	80,675 New	80,675 $1.19 Million

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

Stay updated on Alps Advisors Inc with notifications on news.